Cross-Domain Multi-disease Ocular Disease Recognition via Data Enhancement
preprint
OA: closed
CC-BY-4.0
Abstract
Abstract Ophthalmic diseases afflict many people, and can even lead to irreversible blindness. Therefore, the search for effective early diagnosis methods has attracted the attention of many researchers and clinicians. At present, although there are some ways for the early screening of ophthalmic diseases, the early screening of fundus images based on deep learning is generally favored by the medical community due to its non-contact characteristic, non-invasive characteristic and high recognition accuracy. However, the generalization performance of a common model and cross-domain identification is usually weak due to different collection equipment, race, and patient conditions. Although the existing fundus image recognition technology has achieved some results, the effect is still in the cross-domain problem and is not satisfactory. In this paper, a cross-domain fundus image recognition framework based on deep neural networks with data enhancement is proposed. First, the ResNeXt101 model is chosen as the basic framework. Second, some data enhancement methods and focal loss are used to improve recognition performance. Finally, the results of experiment show that the final score of the framework is improved by about 10% using ordinary data enhancement methods and focal loss. In summary, the method proposed in this paper can effectively solve the problem of poor generalization ability for cross-domain early fundus screening and can provide inspiration and ideas for future related works.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0